Symposium programme
Scientific Program
Chair: Claudiu Supuran
14.30-14.50 Opening ceremony
Luigi Dei (Rector of the University of Florence)
Patrizio Blandina Former Director of Neurofarba and of the Faculty of Pharmacy
Gianluca Sbardella President of the Medicinal Chemistry Division
Claudiu T Supuran - Co-chair of the Organizing Committee
14.50-15.40 Opening lecture
Dario Neri
(ETH Zürich, Switzerland)
FROM ENCODED LIBRARIES TO CLINICAL-STAGE TARGETED THERAPEUTICS
15.40-16.10 KeyNote1
Rita Petracca
(Imperial College London, UK)
RAPID SELECTION OF NOVEL MACROCYCLIC PEPTIDES AS MODULATORS OF RAB27A-EFFECTOR INTERACTIONS
16.10-16.30 Break
Chair: Francesco Di Leva
16.30-17.00 KeyNote2
Marco Pieroni
(University of Parma, Italy)
LIGAND BASED DRUG DESIGN TO EXPAND THE ANTITUBERCULAR ARSENAL
Session A Chair: Francesco Di Leva |
Session B Chair: Isabella Romeo |
17.00-17.20 OC1 |
17.00-17.20 OC5 |
Eleonora Gianquinto (University of Torino, Italy) VIRTUAL SCREENING IDENTIFIES CROSS-CLASS INHIBITORS OF CLINICALLY RELEVANT SERINE- AND METALLO-BETA-LACTAMASES |
Tommaso Felicetti (University of Perugia, Italy) EFFICIENT ONE-STEP SYNTHESIS OF DIFFERENTLY FUNTIONALIZED 1,2,4-TRIAZOLO[1,5-a]PYRIMIDINES |
17.20-17.40 OC2 |
17.20-17.40 OC6 |
Maria Laura Pavone (University of Parma, Italy) NOVEL ADJUVANT STRATEGIES TO OVERCOME ANTIMICROBIAL RESISTANCE |
Maria Chiara Pismataro (University of Perugia, Italy) HYBRID SMALL MOLECULES TARGETING THE PA-PB1 INTERFACE OF INFLUENZA A VIRUS POLYMERASE |
17.40-18.00 OC3 |
17.40-18.00 OC7 |
Laura Mourot (University of Strasbourg, France) OPTIMIZATION OF A NOVEL FAST ACTING TRANSMISSION BLOCKING ANTIMALARIAL AGENT |
Michela Puxeddu (University of Roma “la Sapienza” , Italy) INHIBITION OF ZIKA VIRUS REPLICATION BY NOVEL INHIBITORS OF NS2B/NS3 COMPLEX |
18.00-18.20 OC4 |
18.00-18.20 OC8 |
Pasquale Linciano (University of Pavia, Italy) PHENOTYPIC AND MACHINE LEARNING APPROACHES FOR HIT TO LEAD OPTIMIZATION OF BROAD SPECTRUM NON-TOXIC ANTIPARASITIC AGENTS |
Irina Stefanelli (University of Napoli, Italy) INTEGRATING ARTIFICIAL INTELLIGENCE AND CHEMICAL SYNTHESIS TO DISCOVER NEW POTENT ANTIFLAVIVIRUS AGENTS |
Tuesday 27/4
Chair: Rita Petracca
14.30-15.00 KeyNote3
Azzurra Stefanucci
(University of Chieti-Pescara "G. D'Annunzio" - Winner of the DCF2020 Award)
POTENT, EFFICACIOUS, AND STABLE CYCLIC OPIOID PEPTIDES WITH LONG LASTING ANTINOCICEPTIVE EFFECT AFTER PERIPHERAL ADMINISTRATION
Session A Chair: Rita Petracca |
Session B Chair: Alberto Massarotti |
15.00-15.20 OC9 |
15.00-15.20 OC13 |
Claudia Albertini (University of Bologna, Italy) TURNING CROMOLYN-IBUPROFEN DRUG COMBINATION INTO SINGLE-MOLECULE CONJUGATES POLYPHARMACOLOGICAL APPROACH FOR ALZHEIMER’S DISEASE |
Rebecca Appiani (University of Milano, Italy) BEHAVIOURAL AND PHARMACOLOGICAL PROFILES OF ZEBRAFISH ADMINISTRATED HIGH AFFINITY α4β2 NICOTINIC ACETYLCHOLINE RECEPTORS LIGANDS |
15.20-15.40 OC10 |
15.20-15.40 OC14 |
Eleonora Cescon (University of Trieste, Italy) SCAFFOLD REPURPOSING OF AN IN-HOUSE CHEMICAL LIBRARY: IDENTIFICATION OF NEW CK1δ INHIBITORS |
Davia Prischich (IBEC, Barcellona, Spain) IN VIVO PHOTOPHARMACOLOGY OF ADRENERGIC RECEPTORS |
15.40-16.00 OC11 |
15.40-16.00 OC15 |
Gabriele Carullo (University of Siena, Italy) HARNESSING AN EPIGENETIC APPROACH TO TREAT INHERITED RETINAL DISEASES: SYNTHESIS OF NEW HDAC INHIBITORS ACTIVE IN ZEBRAFISH MODEL OF RETINAL BLINDNESS |
Costanza Ceni(University of Pisa, Italy) NOVEL POTENT AGONISTS OF THE GPR55 RECEPTOR BASED ON THE 3-BENZYLQUINOLIN-2(1H)-ONE SCAFFOLD |
16.00-16.20 OC12 |
16.00-16.20 OC16 |
Samuele Maramai(University of Siena, Italy) SUBTYPE SELECTIVE γ-AMINOBUTYRIC ACID TYPE A RECEPTORS (GABAAR) MODULATORS ACTING AT THE BENZODIAZEPINE BINDING SITE |
Gianmarco Elisi(University of Parma, Italy) MOLECULAR DYNAMICS CHARACTERIZATION OF A LIPOPHILIC PATHWAY FOR THE UNBINDING OF MELATONIN RECEPTOR LIGANDS |
16.20-16.40 Coffee break
Chair: Marco Pieroni
16.40-17.10 KeyNote4
Stella Cascioferro (Università di Palermo)
ANTIBIOFILM STRATEGY IN THE FIGHT AGAINST ANTIBIOTIC RESISTANCE
Session A Chair: Marco Pieroni |
Session B Chair: Paolo Rovero |
17.10-17.30 OC17 |
17.10-17.30 OC20 |
Giulio Poli(University of Pisa, Italy) NEW NONCOVALENT MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS IDENTIFIED THROUGH PHARMACOPHORE-DRIVEN VIRTUAL SCREENING STUDY |
Irene Brusa(University of Bologna, Italy) HIT OPTIMIZATION FOR THE DISCOVERY OF NOVEL RNF5 INHIBITORS AS CORRECTORS OF THE MUTANT CFTR CHLORIDE CHANNEL IN CYSTIC FIBROSIS |
17.30-17.50 OC18 |
17.30-17.50 OC21 |
Nicola Gambacorta(University of Bari, Italy) ARTIFICIAL INTELLIGENCE AND MULTIOBJECTIVE OPTIMIZATION FOR THE DE NOVO DESIGN OF TARGETED CHEMICAL LIBRARIES |
Emma Baglini(University of Pisa, Italy) NOVEL POSITIVE ALLOSTERIC MODULATORS OF A2B ADENOSINE RECEPTOR ACTING AS BONE MINERALIZATION PROMOTERS |
17.50-18.10 OC19 |
17.50-18.10 OC22 |
Giorgio Amendola (University of Campania Luigi Vanvitelli, Italy) PYRMD: USING ARTIFICIAL INTELLIGENCE TO ACCELERATE LIGAND-BASED VIRTUAL SCREENING |
Alessandra Cipriano (Winner of the “2021 Best PhD thesis” award, University of Salerno, Italy) RATIONAL DESIGN, SYNTHESIS, AND IN VITRO EVALUATION OF CELL ACTIVE CHEMICAL PROBES FOR BROMODOMAIN-CONTAINING PROTEINS |
Wednesday 28/4
Chair: Stella Cascioferro
14.30-15.00 KeyNote5
Paolo Rovero
(University of Firenze)
PERSPECTIVES IN PEPTIDE-BASED SARS-COV-2 VACCINATION STRATEGIES
Session A Chair: Stella Cascioferro |
Session B Chair: Giannamaria Annunziato |
15.00-15.20 OC23 |
15.00-15.20 OC27 |
Sara Tengattini(University of Pavia, Italy) CHEMICAL GLYCOSYLATION OF RECOMBINANT AG85 ANTIGENS: ON THE WAY TO A NOVEL TUBERCULOSIS VACCINE |
Giovanna Baron (University of Milano, Italy) METABOLOMIC, PROTEOMIC AND COMPUTATIONAL STUDIES TO EVALUATE THE LIPID-LOWERING AND ANTI-STEATOTIC EFFECTS OF POLYPHENOLS FROM BERGAMOT LEAVES |
15.20-15.40 OC24 |
15.20-15.40 OC28 |
Fosca Errante(University of Firenze, Italy) DESIGN AND SYNTHESIS OF SARS-COV-2 ANTIGENS FOR DIAGNOSTICS AND VACCINOLOGY |
Doretta Cuffaro(University of Pisa, Italy) EXOSITE INHIBITION OF ADAMTS-5 BY A GLYCOCONJUGATED ARYLSULFONAMIDE |
15.40-16.00 OC25 |
15.40-16.00 OC29 |
Rosa Bellavita (University of Napoli, Italy) SELF-ASSEMBLED ANTIMICROBIAL PEPTIDES TO CHALLENGE RESISTANT BACTERIA |
Carlo Matera (University of Milano, Italy) DESIGN, SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF A PHOTOSWITCHABLE INHIBITOR OF FOLATE METABOLISM |
16.00-16.20 OC26 |
16.00-16.20 OC30 |
Lara Davani (University of Bologna, Italy) INVESTIGATION OF Aß PEPTIDE EFFECTS ON SH-SY5Y CELLS: A LIPIDOMIC APPROACH FOR ALZHEIMER’S DISEASE DRUG DISCOVERY |
Niamh O'Mahoney (University College Cork, Ireland) CHARACTERISATION OF PHARMACEUTICAL FORMULATIONS USING BROADBAND ACOUSTIC RESONANCE DISSOLUTION SPECTROSCOPY (BARDS). |
16.20-17.00 Coffee break
Chair: Gabriele Costantino
Round Table: COVID19 VACCINES IN ITALY: CHALLENGES AND OPPORTUNITIES
Roberto Burioni, Università Vita-Salute San Raffaele (Milano, Italy),
Bruno Alfonsi, Director Market Access, BioNet-Asia
Duccio Mattii, Quality Director, GSK
Ruggero Bettini, University of Parma (Italy)
Thursday 29/4
Chair: Azzurra Stefanucci
14.30-15.00 KeyNote6
Francesco Di Leva
University of Napoli "Federico II" – Winner of the DCF2020 Award
MULTIFUNCTIONAL αvβ6 INTEGRIN-TARGETING RGD PEPTIDES: FROM COMPUTER-AIDED DESIGN TO BIOMEDICAL APPLICATIONS
Session A Chair: Azzurra Stefanucci |
Session B Chair: Michele Mari |
15.00-15.20 OC31 |
15.00-15.20 OC34 |
Daniela Carbone(University of Palermo, Italy) THIAZOLE NORTOPSENTIN ANALOGS TARGETING CANCER STEM CELLS: TOWARD THE DEVELOPMENT OF NEW ANTI-COLORECTAL CANCER AGENTS |
Marta Serafini (Winner of the “2021 Best PhD thesis” award, University of Piemonte Orientale, Italy) TARGETING THE KYNURENINE PATHWAY WITH NEW MODALITIES: FROM A VIRTUAL SCREENING TO THE IDENTIFICATION OF TWO NOVEL IDO1 INHIBITORS |
15.20-15.40 OC32 |
15.20-15.40 OC35 |
Caterina Carraro(University of Padova, Italy) DRUG DISCOVERY MEETS OMICS: THE CASE STUDY OF 3-CHLOROPIPERIDINES |
Stefano Sainas (University of Torino, Italy) THE INHIBITION OF HUMAN DHODH BY M433 LEADS TO DIFFERENTIATION AND APOPTOSIS IN ACUTE MYELOID LEUKEMIA |
15.40-16.00 OC33 |
15.40-16.00 OC36 |
Fàbio Pedroso de Lima (University of Minho, Portugal) 3H-CHROMENO[2,3-d]PYRIMIDIN-4(5H)-ONES - SYNTHESIS AND BIOLOGICAL EVALUATION AS ANTICANCER AGENTS |
Alessandra Feoli (University of Salerno, Italy) DEVELOPMENT OF A MICROSCALE THERMOPHORESIS-BASED METHOD FOR SCREENING INHIBITORS OF THE METHYL-LYSINE READER PROTEIN MRG15 |
16.00-16.30 Coffee break
Chair: Maria Novella Romanelli
16.30-16.40 Marco Macchia
(Director of the European School of Medicinal Chemistry)
Presentation of ESMEC 2021
16.40-17.30 Closing lecture
Antonello Mai
University of Roma “La Sapienza”
TOGETHER IS BETTER: EPIGENETIC POLYPHARMACOLOGY
17.30 Gianluca Sbardella, Maria Novella Romanelli
Prizes & Closing remarks